Clinical Trials Directory

Trials / Completed

CompletedNCT04232956

Invasive Pulmonary Aspergillosis and Severe Influenza

Is Invasive Pulmonary Aspergillosis a Common Complication of Severe Influenza ?

Status
Completed
Phase
Study type
Observational
Enrollment
478 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Invasive pulmonary aspergillosis (IPA) has been reported in critically ill patients with influenza infection with a highly variable incidence between 1 to 21%. Studies investigating IPA in critically ill patients with influenza infection suffer limitations in their methods. It remains unknown whether patients with influenza are more at risk of IPA than other patients hospitalized in intensive care unit and whether patients with influenza who develop IPA have specific risk factors for this infection. Our study aims to determine the incidence of IPA in a large multicenter cohort and to identify risk factors for IPA in these patients.

Conditions

Timeline

Start date
2018-07-27
Primary completion
2018-11-05
Completion
2018-11-05
First posted
2020-01-18
Last updated
2020-01-18

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04232956. Inclusion in this directory is not an endorsement.